Company Profile
Updated: 24-MAR-09Bayer Schering Pharma AG
International public company
Muellerstr 178, Berlin, D-13342, Germany
()49 030 468 11 11, 49 030 468 153 05 fax, http://www.bayerscheringpharma.de
Primary SIC: Pharmaceutical Preparations, Primary NAICS: Pharmaceutical Preparation Manufacturing
Description: Manufacturing: Manufacture of and trade in medicaments and pharmaceuticals; research. The four strategic business areas are: gynecology and andrology, specialized therapeutics, diagnostics and radiopharmaceuticals, dermatology
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
New research on metaplasia from University of Heidelberg summarized.
Biotech Week; 11/18/2009; 977 words; ...old man with dialysis-dependent renal failure who was exposed to GCCA [gadopentate dimeglumine (Magnevist; Bayer Schering Pharma AG, Pittsburgh, PA)]. Three months after exposure to GCCA, he developed pruritic, pigmented patches that slowly...
New data from T.U. Bracker et al illuminate research in colon cancer.
Cancer Weekly; 11/10/2009; 1006 words; ...Oncology, 2009;35(4):909-920). Additional information can be obtained by contacting B. Haendler, Bayer Schering Pharma AG, TRG Oncology, Global Drug Discovery, 178 Mullerstr, D-13353 Berlin, Germany. The publisher of the International...
Bayer Consumer Care Launches Citracal(R) Calcium Plus Heart Health, First-Ever Leading Calcium Supplement to Help Support Bone AND Heart Health.
PR Newswire; 11/5/2009; 948 words; ...citracal.com/. About Bayer Consumer Care The...Care division of Bayer HealthCare, is headquartered...New Jersey, USA. Bayer Consumer Care is...subsidiary of Bayer AG, is one of the world...under the name Bayer Schering Pharma and as Bayer HealthCare...
Seattle Genetics Highlights Pipeline Progress and Reports Third Quarter 2009 Financial Results.(Financial report)
Blood Weekly; 11/5/2009; 2227 words; ...547, an anti-EphA2 ADC for solid tumors Received a milestone payment under collaboration with Bayer Schering Pharma AG, Germany, triggered by Bayer's submission of an IND application to the FDA for MN-IC, an ADC for solid tumors SEA Technology...
Other News To Note.
BIOWORLD Today; 11/4/2009; 1947 words; ...algorithms. Cardiome Pharma Corp., of Vancouver...collaboration with Bayer AG, of Leverkusen...Galapagos will provide Bayer with adenoviral vectors...Southampton, UK, and Schering-Plough Corp...an alliance with Schering-Plough, Genome...
Recent News Articles
- Reportlinker Adds Bayer Schering Pharma AG: PharmaVitae Profile.
Business Wire - July 27, 2009 - Bayer Schering Pharma AG - PharmaVitae Profile.
M2 Presswire - June 22, 2009 - Bayer Schering Pharma AG - PharmaVitae Model.
M2 Presswire - May 27, 2009 - Bayer begins European roll-out of Qlaira.(Bayer Schering Pharma AG)(Brief article)
Pharma Marketletter - May 18, 2009
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning
